{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:00:59Z","timestamp":1758265259955,"version":"3.28.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,24]]},"DOI":"10.7759\/cureus.72324","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T21:19:10Z","timestamp":1729804750000},"source":"Crossref","is-referenced-by-count":2,"title":["Advancements in the Management of Pediatric and Adult Inflammatory Bowel Disease: A Systematic Review of Treatment Strategies and Long-Term Outcomes"],"prefix":"10.7759","author":[{"given":"Victor O","family":"Adedara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A","family":"Adedara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola D","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant U","family":"Alozie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nate","family":"Nettagul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Inflammatory Bowel Disease","author":"McDowell C","year":"2023","unstructured":"McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. StatPearls Treasure Islands, Florida; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury M","year":"2014","unstructured":"Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014, 7:113-20. 10.2147\/JIR.S65979","journal-title":"J Inflamm Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082249","article-title":"Inflammatory bowel disease: emerging therapies and future treatment strategies","volume":"11","author":"Bretto E","year":"2023","unstructured":"Bretto E, Ribaldone DG, Caviglia GP, Saracco GM, Bugianesi E, Frara S. Inflammatory bowel disease: emerging therapies and future treatment strategies. Biomedicines. 2023, 11:2249. 10.3390\/biomedicines11082249","journal-title":"Biomedicines"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030747","article-title":"Exploring the pipeline of novel therapies for inflammatory bowel disease: state of the art review","volume":"11","author":"Zurba Y","year":"2023","unstructured":"Zurba Y, Gros B, Shehab M. Exploring the pipeline of novel therapies for inflammatory bowel disease: state of the art review. Biomedicines. 2023, 11:747. 10.3390\/biomedicines11030747","journal-title":"Biomedicines"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: A comprehensive review","volume":"8","author":"Cai Z","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: A comprehensive review. Front Med (Lausanne). 2021, 8:765474. 10.3389\/fmed.2021.765474","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S360248","article-title":"Personalized treatment for Crohn\u2019s disease: current approaches and future directions","volume":"16","author":"Clinton JW","year":"2023","unstructured":"Clinton JW, Cross RK. Personalized treatment for Crohn\u2019s disease: current approaches and future directions. Clin Exp Gastroenterol. 2023, 16:249-76. 10.2147\/CEG.S360248","journal-title":"Clin Exp Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41120","article-title":"Advancements in inflammatory bowel disease: a narrative review of diagnostics, management, epidemiology, prevalence, patient outcomes, quality of life, and clinical presentation","volume":"15","author":"Muzammil MA","year":"2023","unstructured":"Muzammil MA, Fariha F, Patel T, et al.. Advancements in inflammatory bowel disease: a narrative review of diagnostics, management, epidemiology, prevalence, patient outcomes, quality of life, and clinical presentation. Cureus. 2023, 15:e41120. 10.7759\/cureus.41120","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15919","article-title":"Personalized medicine in inflammatory bowel disease: perspectives on Asia","volume":"37","author":"Park SH","year":"2022","unstructured":"Park SH, Park SH. Personalized medicine in inflammatory bowel disease: perspectives on Asia. J Gastroenterol Hepatol. 2022, 37:1434-45. 10.1111\/jgh.15919","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: Targets, mechanisms and related therapies","volume":"71-72","author":"Liu J","year":"2023","unstructured":"Liu J, Di B, Xu LL. Recent advances in the treatment of IBD: Targets, mechanisms and related therapies. Cytokine Growth Factor Rev. 2023, 71-72:1-12. 10.1016\/j.cytogfr.2023.07.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2018.12.03","article-title":"Personalising medicine in inflammatory bowel disease-current and future perspectives","volume":"8","author":"Ashton JJ","year":"2019","unstructured":"Ashton JJ, Mossotto E, Ennis S, Beattie RM. Personalising medicine in inflammatory bowel disease-current and future perspectives. Transl Pediatr. 2019, 8:56-69. 10.21037\/tp.2018.12.03","journal-title":"Transl Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/tp-23-210","article-title":"Recent developments in the assessment and management of inflammatory bowel disease in childhood: a narrative review","volume":"12","author":"Green Z","year":"2023","unstructured":"Green Z, Beattie RM, Ashton JJ. Recent developments in the assessment and management of inflammatory bowel disease in childhood: a narrative review. Transl Pediatr. 2023, 12:1853-74. 10.21037\/tp-23-210","journal-title":"Transl Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000183","article-title":"A treat-to-target update in ulcerative colitis: A systematic review","volume":"114","author":"Ungaro R","year":"2019","unstructured":"Ungaro R, Colombel JF, Lissoos T, Peyrin-Biroulet L. A treat-to-target update in ulcerative colitis: A systematic review. Am J Gastroenterol. 2019, 114:874-83. 10.14309\/ajg.0000000000000183","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.11.015","article-title":"Microbiota and IBD: current knowledge and future perspectives","volume":"56","author":"Foppa C","year":"2024","unstructured":"Foppa C, Rizkala T, Repici A, Hassan C, Spinelli A. Microbiota and IBD: current knowledge and future perspectives. Dig Liver Dis. 2024, 56:911-22. 10.1016\/j.dld.2023.11.015","journal-title":"Dig Liver Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2083","article-title":"Diagnosis and management of inflammatory bowel disease in children","volume":"357","author":"Oliveira SB","year":"2017","unstructured":"Oliveira SB, Monteiro IM. Diagnosis and management of inflammatory bowel disease in children. BMJ. 2017, 357:j2083. 10.1136\/bmj.j2083","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i48.6888","article-title":"Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease","volume":"28","author":"Xu YH","year":"2022","unstructured":"Xu YH, Zhu WM, Guo Z. Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease. World J Gastroenterol. 2022, 28:6888-99. 10.3748\/wjg.v28.i48.6888","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i12.3146","article-title":"Immunosuppressive therapies for inflammatory bowel disease","volume":"20","author":"Zenlea T","year":"2014","unstructured":"Zenlea T, Peppercorn MA. Immunosuppressive therapies for inflammatory bowel disease. World J Gastroenterol. 2014, 20:3146-52. 10.3748\/wjg.v20.i12.3146","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa239","article-title":"Differences in biologic utilization and surgery rates in pediatric and adult Crohn\u2019s Disease: results from a large electronic medical record-derived cohort","volume":"27","author":"Kurowski JA","year":"2021","unstructured":"Kurowski JA, Milinovich A, Ji X, Bauman J, Sugano D, Kattan MW, Achkar JP. Differences in biologic utilization and surgery rates in pediatric and adult Crohn\u2019s Disease: results from a large electronic medical record-derived cohort. Inflamm Bowel Dis. 2021, 27:1035-44. 10.1093\/ibd\/izaa239","journal-title":"Inflamm Bowel Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071735","article-title":"Sphingosine 1-Phosphate modulation in inflammatory bowel diseases: keeping lymphocytes out of the intestine","volume":"10","author":"Dal Buono A","year":"2022","unstructured":"Dal Buono A, Gabbiadini R, Alfarone L, et al.. Sphingosine 1-Phosphate modulation in inflammatory bowel diseases: keeping lymphocytes out of the intestine. Biomedicines . 2022, 10:1735. 10.3390\/biomedicines10071735","journal-title":"Biomedicines"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S293272","article-title":"Anti-Integrins for the treatment of inflammatory bowel disease: current evidence and perspectives","volume":"14","author":"Gubatan J","year":"2021","unstructured":"Gubatan J, Keyashian K, Rubin SJ, Wang J, Buckman CA, Sinha S. Anti-Integrins for the treatment of inflammatory bowel disease: current evidence and perspectives. Clin Exp Gastroenterol. 2021, 14:333-42. 10.2147\/CEG.S293272","journal-title":"Clin Exp Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i20.3624","article-title":"Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3","volume":"23","author":"Afzali A","year":"2017","unstructured":"Afzali A, Wahbeh G. Transition of pediatric to adult care in inflammatory bowel disease: Is it as easy as 1, 2, 3. World J Gastroenterol. 2017, 23:3624-31. 10.3748\/wjg.v23.i20.3624","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2018.00128","article-title":"Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key","volume":"17","author":"Kim J","year":"2019","unstructured":"Kim J, Ye BD. Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key. Intest Res. 2019, 17:24-35. 10.5217\/ir.2018.00128","journal-title":"Intest Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae087","article-title":"Pediatric to adult transition in inflammatory bowel disease: consensus guidelines for Australia and New Zealand","volume":"Online ahead of print","author":"Vernon-Roberts A","year":"2024","unstructured":"Vernon-Roberts A, Chan P, Christensen B, Havrlant R, Giles E, Williams AJ. Pediatric to adult transition in inflammatory bowel disease: consensus guidelines for Australia and New Zealand. Inflamm Bowel Dis. 2024, Online ahead of print:10.1093\/ibd\/izae087","journal-title":"Inflamm Bowel Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051361","article-title":"The interaction between stress and inflammatory bowel disease in pediatric and adult patients","volume":"13","author":"Belei O","year":"2024","unstructured":"Belei O, Basaca DG, Olariu L, et al.. The interaction between stress and inflammatory bowel disease in pediatric and adult patients. J Clin Med. 2024, 13:1361. 10.3390\/jcm13051361","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2019.12.008","article-title":"Pediatric inflammatory bowel disease in Asia: epidemiology and natural history","volume":"61","author":"Huang JG","year":"2020","unstructured":"Huang JG, Aw MM. Pediatric inflammatory bowel disease in Asia: epidemiology and natural history. Pediatr Neonatol. 2020, 61:263-71. 10.1016\/j.pedneo.2019.12.008","journal-title":"Pediatr Neonatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136966","article-title":"Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response","volume":"23","author":"Elhag DA","year":"2022","unstructured":"Elhag DA, Kumar M, Saadaoui M, Akobeng AK, Al-Mudahka F, Elawad M, Al Khodor S.  Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response. Int J Mol Sci. 2022, 23:6966. 10.3390\/ijms23136966","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2022.100089","article-title":"Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises","volume":"3","author":"Alsoud D","year":"2022","unstructured":"Alsoud D, Vermeire S, Verstockt B. Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises. Curr Res Pharmacol Drug Discov. 2022, 3:100089. 10.1016\/j.crphar.2022.100089","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072696","article-title":"Harnessing the power of precision medicine and novel biomarkers to treat Crohn's disease","volume":"12","author":"Kriger-Sharabi OA","year":"2023","unstructured":"Kriger-Sharabi OA, Kopylov U. Harnessing the power of precision medicine and novel biomarkers to treat Crohn's disease. J Clin Med. 2023, 12:2696. 10.3390\/jcm12072696","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/309642-advancements-in-the-management-of-pediatric-and-adult-inflammatory-bowel-disease-a-systematic-review-of-treatment-strategies-and-long-term-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T21:19:12Z","timestamp":1729804752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/309642-advancements-in-the-management-of-pediatric-and-adult-inflammatory-bowel-disease-a-systematic-review-of-treatment-strategies-and-long-term-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.72324","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}